Ligand Chief Legal Officer Sells About $1.03 Million in Shares, Exercises Options
Andrew Reardon, Chief Legal Officer and Secretary of Ligand Pharmaceuticals (LGND), sold 4,858 shares on March 4, 2026, for roughly $1.03 million and exercised options to buy 5,000 shares at $52.27. The trades were carried out under a pre-arranged trading plan. Separately, Ligand posted fourth-quarter and full-year 2025 results that beat analysts' …